(Q42495824)

English

Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Ghamartaj Hossein

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Somayeh Arabzadeh

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Batool Hossein-Rashidi

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Marziyeh Agha Hosseini

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

12 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

413-417

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Anti-Müllerian hormone: a new marker for ovarian function

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Serum anti-Mullerian hormone throughout the human menstrual cycle.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Serum antimüllerian hormone is not predictive of oocyte quality in vitro fertilization.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Direct non-genomic effects of follicular steroids on maturing human oocytes: oestrogen versus androgen antagonism

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Androgens stimulate early stages of follicular growth in the primate ovary

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Polycystic ovary syndrome: anomalies in progesterone production.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Estradiol, progesterone, testosterone profiles in human follicular fluid and cultured granulosa cells from luteinized pre-ovulatory follicles.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Follicular fluid steroid levels in relation to oocyte maturity and in vitro fertilization.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

In controlled ovarian hyperstimulation, steroid production, oocyte retrieval, and pregnancy rate correlate with gene expression of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

FSH priming improves oocyte maturation, but priming with FSH or hCG has no effect on subsequent embryonic development in an in vitro maturation program

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.613964

21 January 2018

Identifiers

10.3109/09513590.2011.613964

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42495824&oldid=1992755366"